In January 2026, the Wadsworth Center successfully completed routine federal inspections required under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) across the Biggs Laboratory, Griffin Laboratory, and the David Axelrod Institute (DAI). A team of five CLIA surveyors conducted a comprehensive three-day on-site evaluation of clinical laboratory operations.
The Griffin Laboratory completed its inspection with no deficiencies identified, demonstrating strong compliance with federal testing, quality, and operational requirements. Inspections of the remaining laboratories identified anticipated compliance findings. At the Biggs Laboratory, two standard-level findings reflected opportunities to further clarify and standardize documentation related to specimen receiving and temperature monitoring practices. At the David Axelrod Institute, the inspection identified expected findings, including one condition-level item; all had been previously recognized and were already incorporated into the Wadsworth Center’s ongoing continuous quality improvement activities.
Across all laboratories, common themes included opportunities to further standardize specimen receiving processes, clarify documentation related to personnel qualifications, and strengthen document review and oversight through the Wadsworth Center Quality Assurance program. Corrective actions are underway and are aligned with planned facility enhancements and standardized quality practices being advanced under the Wadsworth Center 2030 initiative.